MedTech Dive - Latest News

M&A and a separation take center stage in latest earnings season

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

Feb 10, 2025 - 18:12
 0
M&A and a separation take center stage in latest earnings season

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

Read More

Tags:

Previous Article

Why health systems should be ‘clear-eyed’ about business goals for AI tools

Next Article

Buying a Mobile Home: Costs, Financing, and What You Must Know Before You Buy

Related Posts

Siemens Healthineers opening logistics depots in US to boost inventory

Siemens Healthineers opening logistics depots in US to ...

Feb 20, 2025  0

Vicarious Surgical COO John Mazzola to retire

Vicarious Surgical COO John Mazzola to retire

Feb 19, 2025  0

Mitigating tariffs: EY’s Lynlee Brown discusses strategies for medtech

Mitigating tariffs: EY’s Lynlee Brown discusses strateg...

Feb 18, 2025  0